Filing Details

Accession Number:
0001213900-20-034800
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-03 16:03:15
Reporting Period:
2020-11-02
Accepted Time:
2020-11-03 16:03:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1553643 Relmada Therapeutics Inc. RLMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1117167 J Charles Casamento C/O Relmada Therapeutics, Inc.
880 Third Avenue, 12Th Floor
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-02 3,000 $30.29 49,173 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The range of prices for the transaction reported on this line was $30.00 to $31.33. The average weighted price was $30.2879. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.